Skip to main content

Osteopore Health Care

$0.085 -0.001 (-1.16%)

High

$0.09

Low

$0.09

Trades

15

Turnover

$18,591

Volume

214,739
30 June 2023 at 3:31pm
Register to track OSX and receive email alerts.
OSX Announcements on Price Chart

Latest Announcements

Headline Date
Application for quotation of securities - OSX 29 June 2023 at 3:40pm
Notice of Breach of ASX Listing Rule 10.11 26 June 2023 at 6:50pm
Change of Share Registry Details 23 June 2023 at 5:00pm
Shortfall oversubscribed for Osteopore's Global Expansion 20 June 2023 at 9:10am
Strategic Partnership for Clinical R&D in China worth $4M 8 June 2023 at 9:15am
Results of Annual General Meeting 30 May 2023 at 6:10pm
Notification regarding unquoted securities - OSX 25 May 2023 at 7:05pm
Largest South African Medical Insurer provides cover for OSX 16 May 2023 at 8:45am
Notification regarding unquoted securities - OSX 12 May 2023 at 4:50pm
Change of Registered Office 5 May 2023 at 3:15pm
Change of Director's Interest Notice - TSH 28 April 2023 at 7:05pm
Change of Director's Interest Notice - ML 28 April 2023 at 7:05pm
Notice of Annual General Meeting 28 April 2023 at 9:50am
Activities Update Qtr Ending March 2023 and Appendix 4C 28 April 2023 at 8:50am
OSX Successfully transitions to EU Medical Device Regulation 27 April 2023 at 8:55am
Reinstatement of Security Class to Quotation 26 April 2023 at 8:10am
Top 20 and Distribution List - Options 26 April 2023 at 8:10am
Application for quotation of securities - OSX 24 April 2023 at 6:45pm
Application for quotation of securities - OSX 24 April 2023 at 12:25pm
Security Class Suspension from Quotation 24 April 2023 at 12:25pm
Non-Renounceable Entitlement Offer - Results 24 April 2023 at 10:05am
Osteopore Increases Presence in Singapore Dental Market 14 April 2023 at 7:00pm
Osteopore to Commercialise Innovative Bone Rengeneration Tec 14 April 2023 at 9:35am
Employee Securities Incentive Plan 13 April 2023 at 7:40pm
Non-Renounceable Entitlement Offer - Closing Date 13 April 2023 at 10:25am
OSX Strengthens Presence in the Eastern Region of the USA 11 April 2023 at 8:50am
Annual General Meeting Date 5 April 2023 at 12:40pm
Results of General Meeting 31 March 2023 at 5:35pm
Appendix 4G and Corporate Governance Statement 31 March 2023 at 4:50pm
Annual Report to Shareholders 31 March 2023 at 4:50pm
OSX Completes Acquisition to Accelerate Revenue Growth 31 March 2023 at 10:00am
Update - Proposed issue of securities - OSX 30 March 2023 at 6:55pm
Non-Renounceable Entitlement Offer Extension 30 March 2023 at 11:50am
OSX Product Approved for Additional Applications in Taiwan 27 March 2023 at 9:59am
Prospectus despatched 21 March 2023 at 7:05pm
Update - Proposed issue of securities - OSX 14 March 2023 at 6:00pm
Letter to Optionholders 13 March 2023 at 10:15am
Letter to Ineligible Shareholders 13 March 2023 at 10:15am
Proposed issue of securities - OSX 13 March 2023 at 10:15am
Letter to Eligible Shareholders 13 March 2023 at 10:15am
Non-Renounceable Entitlement Offer Prospectus 13 March 2023 at 9:20am
Non-Renounceable Entitlement Offer 13 March 2023 at 9:10am
Notice of General Meeting/Proxy Form 2 March 2023 at 5:30pm
Appendix 4E Preliminary Final Report 28 February 2023 at 7:10pm
Osteopore Advisory Panel of Distinguished Industry Leaders 27 February 2023 at 9:25am
Investor Presentation 20 February 2023 at 10:10am
OSX Enters Orthopaedic Market in Great Britain 14 February 2023 at 9:20am
Activities Update Qtr Ending December 2022 and Appendix 4C 31 January 2023 at 10:40am
Appointment of Joint Company Secretary 25 January 2023 at 7:00pm
Integration of Acquired Business for Higher Sales & Margin 23 January 2023 at 8:45am
Register to track OSX and receive email alerts.